AXA World Funds - Switzerland Equity A Capitalisation CHFRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.0 | 18.2 | -11.7 | 8.0 | 1.0 | |
+/-Cat | 3.6 | -1.8 | -3.0 | -3.0 | 1.0 | |
+/-B’mrk | - | -4.2 | -4.5 | -0.7 | 1.2 | |
Category: Switzerland Equity | ||||||
Category Benchmark: Morningstar Switzerland TME... |
Key Stats | ||
NAV 25/04/2024 | CHF 84.97 | |
Day Change | -1.35% | |
Morningstar Category™ | Switzerland Equity | |
ISIN | LU0087657150 | |
Fund Size (Mil) 25/04/2024 | CHF 310.84 | |
Share Class Size (Mil) 25/04/2024 | CHF 117.37 | |
Max Initial Charge | 5.50% | |
Ongoing Charge 28/02/2023 | 1.77% |
Investment Objective: AXA World Funds - Switzerland Equity A Capitalisation CHF |
To seek long-term growth of your investment, in CHF, from an actively managed listed equity, equity-related securities and derivatives portfolio. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Hervé Mangin 18/12/2017 | ||
Benoit Labeyrie 27/01/2023 | ||
Inception Date 20/06/1990 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
60% SPI Middle Caps TR CHF , 40% SPI Large Caps TR CHF | Morningstar Switzerland TME NR CHF |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for AXA World Funds - Switzerland Equity A Capitalisation CHF | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Nestle SA | Consumer Defensive | 8.49 |
Roche Holding AG | Healthcare | 5.90 |
Julius Baer Gruppe AG | Financial Services | 4.42 |
Lonza Group Ltd | Healthcare | 4.41 |
Novartis AG Registered Shares | Healthcare | 4.16 |
Increase Decrease New since last portfolio | ||
AXA World Funds - Switzerland Equity A Capitalisation CHF |